Correlation Between Aerovate Therapeutics and Pliant Therapeutics
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Pliant Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Pliant Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Pliant Therapeutics, you can compare the effects of market volatilities on Aerovate Therapeutics and Pliant Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Pliant Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Pliant Therapeutics.
Diversification Opportunities for Aerovate Therapeutics and Pliant Therapeutics
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Aerovate and Pliant is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Pliant Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pliant Therapeutics and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Pliant Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pliant Therapeutics has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Pliant Therapeutics go up and down completely randomly.
Pair Corralation between Aerovate Therapeutics and Pliant Therapeutics
Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 0.09 times more return on investment than Pliant Therapeutics. However, Aerovate Therapeutics is 10.6 times less risky than Pliant Therapeutics. It trades about -0.19 of its potential returns per unit of risk. Pliant Therapeutics is currently generating about -0.21 per unit of risk. If you would invest 258.00 in Aerovate Therapeutics on November 30, 2024 and sell it today you would lose (16.00) from holding Aerovate Therapeutics or give up 6.2% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Aerovate Therapeutics vs. Pliant Therapeutics
Performance |
Timeline |
Aerovate Therapeutics |
Pliant Therapeutics |
Aerovate Therapeutics and Pliant Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Aerovate Therapeutics and Pliant Therapeutics
The main advantage of trading using opposite Aerovate Therapeutics and Pliant Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Pliant Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pliant Therapeutics will offset losses from the drop in Pliant Therapeutics' long position.Aerovate Therapeutics vs. Adagene | ||
Aerovate Therapeutics vs. Acrivon Therapeutics, Common | ||
Aerovate Therapeutics vs. Rezolute | ||
Aerovate Therapeutics vs. AN2 Therapeutics |
Pliant Therapeutics vs. Relay Therapeutics | ||
Pliant Therapeutics vs. Stoke Therapeutics | ||
Pliant Therapeutics vs. Black Diamond Therapeutics | ||
Pliant Therapeutics vs. Arvinas |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |